Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Heidi C. Waters, Maelys Touya, Soon Nan Wee, Michelle Ng, Simran Thadani, Subina Surendran, Miguel Rentería, A. John Rush, Rashmi Patel, Joydeep Sarkar, Heather M. Fitzgerald & Xue Han. (2023) Psychiatric healthcare resource utilization following initiation of aripiprazole once-monthly: a retrospective real-world study. Current Medical Research and Opinion 39:2, pages 299-306.
Read now
Read now
Joel Ketola, Erfan Jahangiri, Helinä Hakko, Pirkko Riipinen & Sami Räsänen. (2022) Assisted living for mentally ill—a systematic literature review and its recommendations. Nordic Journal of Psychiatry 76:6, pages 403-422.
Read now
Read now
Eren Yıldızhan, Eda Uzun & Nesrin Buket Tomruk. (2022) Effect of long acting injectable antipsychotics on course and hospitalizations in bipolar disorder – a naturalistic mirror image study. Nordic Journal of Psychiatry 76:1, pages 37-43.
Read now
Read now
Jennifer Munday, Mallik Greene, Eunice Chang, Ann Hartry, Tingjian Yan & Michael S. Broder. (2019) Early initiation of long-acting injectable antipsychotic treatment is associated with lower hospitalization rates and healthcare costs in patients with schizophrenia: real-world evidence from US claims data. Current Medical Research and Opinion 35:7, pages 1231-1239.
Read now
Read now
Articles from other publishers (7)
Laura Orsolini, Sofia Pacini Biagiotti, Lorenzo Maria Martino & Umberto Volpe. (2024) A case report of LAI two injection start in a 16-year-old adolescent with severe manic episode and comorbid cannabinoid use disorder. Asian Journal of Psychiatry 94, pages 103992.
Crossref
Crossref
Joshua Caballero, Jianing Xu, Daniel B. Hall, Xianyan Chen & Henry N. Young. (2023) Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data. Mental Health Clinician 13:4, pages 183-189.
Crossref
Crossref
Emmanuel Stip, Syed Javaid, Jonathan Bayard-Diotte, Karim Abdel Aziz & Danilo Arnone. (2020) Use of long acting antipsychotics and relationship to newly diagnosed bipolar disorder: a pragmatic longitudinal study based on a Canadian health registry. Therapeutic Advances in Psychopharmacology 10, pages 204512532095711.
Crossref
Crossref
Kamyar Keramatian, Trisha Chakrabarty & Lakshmi N. Yatham. (2019) Long-Acting Injectable Second-Generation/Atypical Antipsychotics for the Management of Bipolar Disorder: A Systematic Review. CNS Drugs 33:5, pages 431-456.
Crossref
Crossref
Tingjian Yan, Mallik Greene, Eunice Chang, Michael S Broder, Maëlys Touya, Jennifer Munday & Ann Hartry. (2019) Hospitalization risk factors in antipsychotic-treated schizophrenia, bipolar I disorder or major depressive disorder. Journal of Comparative Effectiveness Research 8:4, pages 217-227.
Crossref
Crossref
Tingjian Yan, Mallik Greene, Eunice Chang, Maëlys Touya & Michael S Broder. (2018) Impact of initiating long-acting injectable antipsychotics on hospitalization in patients with bipolar I disorder. Journal of Comparative Effectiveness Research 7:11, pages 1083-1093.
Crossref
Crossref
Michael S. Broder, Mallik Greene, Eunice Chang, Ann Hartry, Maëlys Touya, Jennifer Munday & Tingjian Yan. (2018) Health Care Resource Use, Costs, and Diagnosis Patterns in Patients With Schizophrenia and Bipolar Disorder: Real-world Evidence From US Claims Databases. Clinical Therapeutics 40:10, pages 1670-1682.
Crossref
Crossref